Cargando…
A nanobody targeting carcinoembryonic antigen as a promising molecular probe for non-small cell lung cancer
Carcinoembryonic antigen (CEA) is a biomarker and therapy target for non-small cell lung cancer (NSCLC), which is the most common type of lung cancer. Nanobodies with high target specificity are promising candidates to function as anti-CEA probes. In the present study, the targeting effects of an an...
Autores principales: | Wang, Hao, Meng, Ai-Min, Li, Sheng-Hua, Zhou, Xiao-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482067/ https://www.ncbi.nlm.nih.gov/pubmed/28586008 http://dx.doi.org/10.3892/mmr.2017.6677 |
Ejemplares similares
-
Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen
por: Hong, Hao, et al.
Publicado: (2008) -
A Carcinoembryonic Antigen-Secreting Adenocarcinoma Arising in Tailgut Cyst : Clinical Implications of Carcinoembryonic Antigen
por: Cho, Byoung Chul, et al.
Publicado: (2005) -
On-bead DNA synthesis triggered by allosteric probe for detection of carcinoembryonic antigen
por: Ling, Min, et al.
Publicado: (2022) -
Affimers and nanobodies as molecular probes and their applications in imaging
por: Cordell, Paul, et al.
Publicado: (2022) -
The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma
por: Kim, Jae Jun, et al.
Publicado: (2015)